Free shipping on all orders over $ 500

D-JNKI-1

Cat. No. M14157
D-JNKI-1 Structure
Synonym:

AM-111; XG-102; Brimapitide

Size Price Availability
5mg USD 360  USD360 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

D-JNKI-1 (AM-111) is a highly potent and cell-permeable peptide inhibitor of JNK.

Chemical Information
Molecular Weight 3822.44
CAS Number 1445179-97-4
Solubility (25°C) DMSO ≥ 90 mg/mL
Water ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Junling Zhao, et al. The Ameliorative Effect of JNK Inhibitor D-JNKI-1 on Neomycin-Induced Apoptosis in HEI-OC1 Cells

[2] Adrien A Eshraghi, et al. Preclinical and clinical otoprotective applications of cell-penetrating peptide D-JNKI-1 (AM-111)

[3] Sabine Kersting, et al. The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium

[4] Yi Zhao, et al. The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria

[5] Adrien A Eshraghi, et al. D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma

Related JNK Products
YL5084 

YL5084, a covalent JNK inhibitor, exhibits selectivity for JNK2 and JNK3 over JNK1 with IC50s of 70 nM, 84 nM and 2173 nM, respectively. YL5084 exhibits JNK2-independent antiproliferative effects and induces apoptosis in a JNK2-independent manner.

SR-3306 

SR-3306 is a selective, potent, highly brain penetrant JNK inhibitor.

CC-90001

CC-90001 is a JNK (c-Jun N-terminal kinase) inhibitor that can be used as a Phase II clinical candidate to study idiopathic pulmonary fibrosis.

SU3327

SU3327 is a potent, selective and substrate-competitive JNK inhibitor with an IC50 of 0.7 μM.

L-JNKI-1

L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK.

  Catalog
Abmole Inhibitor Catalog




Keywords: D-JNKI-1, AM-111; XG-102; Brimapitide supplier, JNK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.